More News

21 Jan 2021 Servier and MiNA Therapeutics Enter Collaboration in Neurological Diseases
20 Jan 2021 Turnstone Biologics Acquires Novel Cell Therapy Platform
18 Jan 2021 Cure Genetics Collaborates with Boehringer Ingelheim to Develop Novel AAV Vectors Enabling the Next-generation Liver-targeted Gene Therapy
15 Jan 2021 Ubiquigent and the University of York Awarded a Grant to Explore the Potential of Deubiquitylase (DUB) Enzyme Inhibitors to Address Neglected Tropical Diseases
15 Jan 2021 Syntekabio Signs Joint Development Agreement with Hanmi Science
13 Jan 2021 Sarepta Therapeutics and Genevant Sciences Announce Research Collaboration for Lipid Nanoparticle-Based Gene Editing Therapeutics
13 Jan 2021 EVOQ Therapeutics Announces a License And Collaboration Agreement with Amgen
13 Jan 2021 Actinium and Astellas Announce Research Collaboration Focused on Novel Actinium-225 Based Targeted Radiotherapies
12 Jan 2021 La Jolla Pharmaceutical Company Announces Exclusive Licensing Agreement for GIAPREZA™ (Angiotensin II) and XERAVA™ (Eravacycline) in Europe
12 Jan 2021 Boehringer Ingelheim and Enara Bio Enter Strategic Collaboration and Licensing Agreement to Discover Novel Shared Antigens for Cancer Immunotherapies
11 Jan 2021 Myeloid Therapeutics and MaxCyte Enter Clinical and Commercial Licensing Agreement to Advance Myeloid's Cell Therapy Programs
11 Jan 2021 Eligo Bioscience inks deal with GSK potentially worth up to $224 million
10 Jan 2021 Chimerix Acquires Oncoceutics to Expand Pipeline with Late-Stage Oncology Program
08 Jan 2021 Precision BioSciences Announces Closing of In Vivo Gene Editing Collaboration and License Agreement with Eli Lilly and Company
08 Jan 2021 Nurix Therapeutics Announces Expansion of its Strategic Collaboration with Sanofi to Develop Novel Targeted Protein Degradation Therapies
07 Jan 2021 Almirall and Tyris Therapeutics enter into strategic partnership to develop next generation gene therapies
07 Jan 2021 Biohaven Acquires Kleo Pharmaceuticals And Licenses Platform Technology From Yale University To Form Biohaven Labs
07 Jan 2021 Werewolf Therapeutics Completes $72 Million Series B Financing to Advance a Novel Class of Cancer Biotherapeutics to the Clinic
06 Jan 2021 Dewpoint Announces Collaboration with Pfizer to Develop Potential Therapies for a Rare Form of Muscular Dystrophy
06 Jan 2021 Kite and Oxford BioTherapeutics Establish Cell Therapy Research Collaboration in Blood Cancers and Solid Tumors
30 Dec 2020 Incyte and Cellenkos Enter into Global Development Collaboration Agreement for CK0804
23 Dec 2020 Agios to Focus on Developing and Commercializing Innovative Treatments for Genetically Defined Diseases and Sell Its Oncology Business to Servier for Up to $2 Billion Plus Royalties
23 Dec 2020 Amgen Licenses AMG 634, An Investigational Treatment For Tuberculosis And Leprosy, To Medicines Development for Global Health
23 Dec 2020 ImmunityBio and NantKwest to Merge, Creating a Leading Immunotherapy and Cell Therapy Company
22 Dec 2020 Servier and Celsius Therapeutics Announce Target Discovery Collaboration in Colorectal Cancer

La Merie Biologics

FREE Weekly News Bulletin

Sign Up

2020 Sales ofAntibodies & Proteins

New Product Alert

For La Merie Publishing

Sign Up

Top